General Description
A panel containing 18 potent, selective and cell-permeable inhibitors and 1 activator that is useful for the study of p53 pathway:2 mg of ATM Kinase Inhibitor (Cat. No. 118500),5 mg ATM/ATR Kinase Inhibitor (Cat. No. 118501),10 mg of Anacardic Acid (Cat. No. 172050),5 mg of Cdk1 Inhibitor IV, RO-3306 (Cat. No. 217699),5 mg of Casein Kinase II Inhibitor III, TBCA (Cat. No. 218710),1 mg of Chk2 Inhibitor II (Cat. No. 220486),5 mg of Hdm2 E3 Ligase Inhibitor (Cat. No. 373225),5 mg of JNK Inhibitor II (Cat. No. 420119),1 mg of MDM2 Antagonist, Nutlin-3, Racemic (Cat. No. 444143),10 mg of MDMX Inhibitor, SJ-172550 (Cat. No. 444155),5 mg of MG-132 (Cat. No. 474790),5 mg of p21-Activated Kinase Inhibitor III, IPA-3 (Cat. No. 506106),5 mg of Pifithrin-α (Cat. No. 506132),1 mg of PI-103 (Cat. No. 528100),1 mg of PARP Inhibitor VIII, PJ34 (Cat. No. 528150),10 mg of PPM1D Phosphatase Inhibitor (Cat. No. 529578),10 mg of PRIMA-1 (Cat. No. 530050),1 mg of Caspase Inhibitor I (Cat. No. 627610),and 1 mg Trichostatin A, Streptomyces sp. (Cat. No. 647925).Also provided with 15 ml of anhydrous DMSO (Cat. No. KP31817). Supplied with a data sheet.
